OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Chemotherapy is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis	22
Nivolumab-induced Lambert-Eaton myasthenic syndrome: an immune-related adverse event in nonsmall cell lung cancer	20
The use of antiviral drugs in children	19
Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy	17
Enzalutamide combination with Arsenic trioxide suppresses the progression of castration-resistant prostate cancer	16
MiR-302a-3p reduces cisplatin resistance of esophageal squamous cell carcinoma cells by targeting EphA2	16
Optimization of the vancomycin administration regimen by clinical pharmacists based on a population pharmacokinetics model: a prospective interventional study	15
Comparative in vitro activities of eravacycline in combination with colistin, meropenem, or ceftazidime against various Achromobacter spp. strains isolated from patients with cystic fibrosis	14
Comparative effectiveness of chemotherapy in different histological types of pancreatic cancer: a PSM-based study using the SEER database	14
Piperacillin/Tazobactam is associated with a higher risk of acute kidney injury compared to cefepime and meropenem	12
Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam	12
YAP/TAZ axis was involved in the effects of metformin on breast cancer	12
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae	12
Successful treatment of persistent SARS-CoV-2 infection with nirmatrelvir/ritonavir plus sotrovimab in four immunocompromised patients	12
A cost minimisation analysis comparing oral linezolid and intravenous daptomycin administered via an outpatient parenteral antibiotic therapy programme in patients requiring prolonged antibiotic cours	11
Rs3802278 in 3’-UTR ofSULF1associated with platinum resistance and survival in Chinese epithelial ovarian cancer patients	11
Reevaluating immunotherapy’s potential in first-line metastatic urothelial carcinoma	11
Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma	10
Comparison of lorlatinib, alectinib and brigatinib in ALK inhibitor–naive/untreated ALK-positive advanced non-small-cell lung cancer: a systematic review and network meta-analysis	10
Activity of ceftolozane-tazobactam, ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol and comparators against Gram-negative organisms causing bloodstream infections in Northern Italy (2019–202	10
Reversible chemoresistance of pancreatic cancer grown as spheroids	10
Current status of systemic therapy in head and neck cancer	10
Causative agents of bloodstream infections in two Croatian hospitals and their resistance mechanisms	10
Importance of daptomycin dosage on the clinical outcome in liver transplant recipients with vancomycin-resistant enterococci infection	9
Identification of chemoresistance targets in doxorubicin-resistant lung adenocarcinoma cells using LC-MS/MS-based proteomics	9

Dual targeting Bcl-2 and Bcl-xL augments osteosarcoma response to doxorubicin	9
The pharmacokinetics of ganciclovir during prolonged intermittent kidney replacement therapy in a cardiac transplant recipient	9
Clinical benefit of PD-1/PD-L1 inhibitors for poor performance status patients with advanced non-small cell lung cancer	8
Developing new drugs for adult T-cell leukemia/lymphoma by targeting hypoxia: insights from toxicity of MS-275 and its analogs	8
The relationship between statin administration timing and survival outcomes in patients with cancer receiving immune checkpoint blockade	8
Initial trough concentration may be beneficial in preventing linezolid-induced thrombocytopenia	8
Relationship between the change in tumour-infiltrating lymphocyte level and residual tumour after neoadjuvant chemotherapy in patients with locally advanced breast cancer	8
Exploring the role of quercetin on doxorubicin and lapatinib-mediated cellular and mitochondrial responses using in vitro and in silico st	8
Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status	7
In vitro killing of multidrug/extensively drug-resistant Pseudomonas aeruginosa by fosfomycin alone or in combination with antipseudomonal antibiotics	7
Effect of HDAC9 inhibition on epithelial-mesenchymal transition in CD133+ prostate cancer cell lines	7
Impact of clinical pharmacist’s interventions on clinical outcomes in appropriate use of colistin: a prospective pre-post intervention study	7
The role of maintenance therapy in the treatment of advanced urothelial cancer: a comprehensive systematic review and network meta-analysis	7
Systematic review and meta-analysis of the predictive power of MTHFR polymorphisms for pemetrexed drug efficacy and toxicity in non-small cell lung cancer patients	7
Review of real-world experience with lurbinectedin in relapsed/refractory small cell lung cancer	7
Inhibiting effect of p-Coumaric acid on U87MG human glioblastoma cell growth	7
Capecitabine-associated enterocolitis: Narrative literature review of a rare adverse event and a case presentation	7
Triptolide inhibits T-cell acute lymphoblastic leukaemia by affecting aberrant epigenetic events in the Wnt signalling pathway	6
Emerging role of competing endogenous RNA in lung cancer drug resistance	6
Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells	6
Advances in MUC1 resistance to chemotherapy in pancreatic cancer	6
High dose methotrexate in adult Egyptian patients with hematological malignancies: impact of ABCB1 3435C > T rs1045642 and MTHFR 677C > T rs1801133 polymorphisms on toxicities and delayed elimin	6
Examining cardiac toxicity in HER2-positive breast cancer patients using trastuzumab and its influencing factors at Iran Hospital	6
In vitro susceptibility of carbapenem-resistant Enterobacterales to eravacycline – the first report from Croatia	6
Hypomethylating agents combined with low-dose chemotherapy for elderly patients with acute myeloid leukaemia unfit for intensive chemotherapy: a real-world clinical experience	6
CircRNA_001895 promotes sunitinib resistance of renal cell carcinoma through regulation of apoptosis and DNA damage repair	5
METTL3-mediated m6A modification promotes chemoresistance of intrahepatic cholangiocarcinoma by up-regulating NRF2 to inhibit ferroptosis in cisplatin-resistant cells	5
Meta-analysis of the efficacy and adverse effects of acalabrutinib in the management of relapsed/refractory chronic lymphocytic leukemia	5
Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis	5
Antimicrobial dosing recommendations during continuous renal replacement therapy: different databases, different doses	5
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success story	5
LncRNA POU6F2-AS2 contributes to malignant phenotypes and paclitaxel resistance by promoting SKP2 expression in stomach adenocarcinoma	5
miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway	5
Comparison of Syrian generic ceftriaxone sodium preparations for injection: BHT content and its implications	5
Dalbavancin treatment for spondylodiscitis: multi-center clinical experience and literature review	5
Neurological toxicities with poly (ADP-ribose) polymerase inhibitors in cancer patients: a systematic review and meta-analysis	4
Clinical outcome and safety profile of metastatic pancreatic cancer patients treated with more than six cycles of nab-paclitaxel plus gemcitabine	4
Infective endocarditis by Serratia species: a systematic review	4
Anti-programmed death ligand 1 immunotherapy in patients with limited-stage small cell lung cancer: a real-world exploratory study	4
Prognostic implications of response to neoadjuvant chemotherapy in breast cancer subtypes	4
Class 1, 2 and 3 integrons in clinical Pseudomonas aeruginosa isolated from Tanta University Hospitals, Egypt	4
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza	4
Improving therapeutic resistance: beginning with targeting the tumor microenvironment	4
The tumor microenvironment: shaping cancer progression and treatment response	4
In vitro activity of newer β-lactam/β-lactamase inhibitor combinations, cefiderocol, plazomicin and comparators against carbapenemase-producing Klebsiella pneumoniae<	4
Impact of ward pharmacist-led antimicrobial stewardship in intensive care units	4
Impact of a hospital sepsis management protocol on the selection of empirical antibiotics in infectious disease consultations	4
Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes in breast cancer patients: a systematic review study	4
Aberrant epigenetic regulation of FZD3 by TET2 is involved in ovarian cancer cell resistance to cisplatin	4
Benefit from Almonertinib after Osimertinib treat EGFR 19 exon deletion NSCLC induced Severe rash: a case report	4

Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey	3
Comparative incidence of acute kidney injury in patients on vancomycin therapy in combination with cefepime, piperacillin-tazobactam or meropenem	3
Pediatric impetigo: an expert panel opinion about its main controversies	3
Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression	3
In vitro and in vivo comparison of eravacycline- and tigecycline-based combination therapies for tigecycline-resistant Acinetobacter baumannii	3
Evaluation of in vitro activity of ceftaroline, ceftobiprole and their combination with trimethoprim/sulfamethoxazole against MRSA isolates: a two center study	3
Case series of metastatic breast cancer patients with visceral crisis treated with CDK4/6 inhibitors	3
Assessment of in vitro interactions between delafloxacin and other antimicrobials against multi-drug resistant Pseudomonas aeruginosa strains	3
Are there differences between ceftolozane/tazobactam and ceftazidime/avibactam in treating patients with complicated abdominal infections? Evidence from clinical trials	3
Varicella zoster virus reactivation reported with isatuximab use	3
Successful treatment with oxaliplatin and programmed cell death protein 1 inhibitor in recurrent advanced endometrial carcinoma with mismatch repair defects: a case report and literature review	3
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge	3
STAT3 and STAT6 polymorphisms predict the severity of adverse reactions in Chinese NSCLC patients receiving EGFR-TKIs therapy	3
Antihyperlipidemic drug rosuvastatin suppressed tumor progression and potentiated chemosensitivity by downregulating CCNA2 in lung adenocarcinoma	3
Time to reconsider moxifloxacin anti-anaerobic activity?	3
Global status of phenotypic pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates: an updated systematic review and meta-analysis	3
Resveratrol suppresses NSCLC cell growth, invasion and migration by mediating Wnt/β-catenin pathway via downregulating SIX4 and SPHK2	3
The BioWipe: a non-invasive method to detect intestinal carriage of multi-drug resistant GRAM-negative bacteria	3
Colistin resistance among the Gram-negative nosocomial pathogens in India: a systematic review and meta-analysis	3
Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways	3
Prognostic and immunological values of SKA3 for overall survival in lung adenocarcinoma and its RNA binding protein involved mechanisms	3
Are small lymphocytic lymphoma and chronic lymphocytic leukemia the same disease? The unsolved dilemma	3
Potential role of genetic polymorphisms in neoadjuvant chemotherapy response in breast cancer	3
Clinical value of circulating tumour cells in evaluating the efficacy of continuous hepatic arterial infusion among colorectal cancer patients	3
Case report: hypertrophic osteoarthropathy improves with immune checkpoint inhibitor therapy	3
Calcium-oxidative stress signaling axis and casein kinase 1α mediate eryptosis and hemolysis elicited by novel p53 agonist inauhzin	3